. رمضانخانی، اعظم. (1395). "تأثیر 16 هفته محدودیت کالریک بر سطوح آیریزین سرم و شاخص مقاومت به انسولین در زنان چاق کم تحرک". علوم غذایی و تغذیه، شماره 2، صص 105-99.
2.Aydin, S., Kuloglu, T., Yilmaz, M., et al. (2013).“Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45min of a Turkish bath or running”. Peptides,50: PP: 13-8.
3.
Blüher, S.,
Panagiotou, G.,
Petroff, D., et al. (2014).
“Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children”.Obesity, 22(7): PP: 1701-8.
4.Boström, P., Wu, J., Jedrychowski, M.P., et al. (2012). “A PGC1α dependent myokine that drives brown-fat-like development of white fat and thermogenesis”. Nature, 481(7382): PP: 463-8.
5.Choi, Y.K., Kim, M.K., Bae, K.H., et al. (2013). “Serum irisin levels in new-onset type 2 diabetes”. Diabetes Res ClinPract, 100(1): PP: 96-101.
6.Crujeiras, A.B., Pardo, M., Arturo, R.R., et al. (2014). “Longitudinal variation of circulating irisin after an energy restrictioninduced weight loss and following weight regain in obese men and women”. Am J Hum Biol, 26(2): PP: 198-207.
7.
Crujeiras, A.,
Zulet, M.A.,
Lopez-Legarrea, P., et al. (2014).
“Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients”.Metabolism, 63(4): PP: 520-531.
8.Daskalopoulou, S.S., Cooke, A.B., Gomez, Y.H., et al. (2014). “Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects”. Eur J Endocrinol, 171(3): PP: 343-52.
9.Hammond, K.A. (2000). “Dietary clinical assessment. In: L Kathleen Mahan LX, Sylvia “Escott-stump” (Editors). Krause’s Food & diet therapy”. 10th ed. Philadelphia: W.B Saunders Company, Philadelphia, PP: 353-37.
10.Hecksteden, A., Wegmann, M., Steffen, A., et al. (2013).“Irisin and exercise training in humans-Results from a randomized controlled training trial”. BMC Med, 11(1): PP: 235.
11.Huh, J.Y., Panagiotou, G., Mougios, V., et al. (2012). “FNDC5 and irisin in humans. I. Predictors of circulating concentrationsin serum and plasma and II. mRNA expression and circulating concentrationsin response to weight loss and exercise”. Metabolism, 61: PP: 1725–38.
12.
Huth, C.,
Marette, A.,
Tremblay, A., et al. (2014).
“Plasma irisin is associated with insulin resistance in men”. FASEB Journal, 28(1): PP: 854.
13.Iglesia, R., Lopez-Legarrea, P., Crujeiras, A.B., et al. (2014).“Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients”. Clinical Endocrinology, 81(2): PP: 306-311.
14.Lecker, S.H., Zavin, A., Cao, P., et al. (2012). “Expression of the irisin precursor FNDC5 in skeletal musclecorrelates with aerobic exercise performance in patients with heart failure”. Circ Heart Fail, 5(6): PP: 812-8.
15.Lee, P., Linderman, J.D., et al. (2014). “Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans”. Cell Metab, 19: PP: 302–9.
16.Kraemer, R., Shockett, P., Webb, N., et al. (2014). “A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women”. Horm Metab Res, 46(02): PP: 150-4.
17.Lefevre, M., Redmana, L.M., Heilbronn, L.K. “Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals”. Atherosclerosis, 203: PP: 206–213.
19.Lopez-Legarrea, P., Iglesia, R., Crujeiras, A.B., et al. (2014). “Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects”. Nutrition & Diabetes, 4: PP: e110.
20.Moreno-Navarrete, J.M., Ortega, F., Serrano, M., et al. (2013). “Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance”. EndocrinolMetab, 98(4): PP: E769–E778.
21.Moreno, M., Moreno-Navarrete, J.M., Serrano, M., et al. (2015).“Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects”.PLoS ONE, 10(4): PP: 1-11.
22.Norheim, F., Langleite, T.M., Hjorth, M., et al.(2014). “The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans”.FEBS Journal, 281(3): PP: 739-749.
23.Pardo, M., Crujeiras, A.B., Amil, M., et al. “Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index”. International Journal of Endocrinology, 2014: PP: 1-9.
24.Park, K.H., Zaichenko, L., Peter, P., et al. (2014). “Diet quality is associated with circulating C-reactive protein but not irisin levels in humans”. Metabolism, 63: PP: 233–241.
25.Pekkala, S., Wiklund, P.K., Hulmi, J.J., et al. (2013). “Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?” J Physiol, 591(21): PP: 5393-400.
26.
Polyzos, S.A.,
Kountouras, J.,
Anastasilakis, A.D., et al.
“Irisin in patients with nonalcoholic fatty liver disease”. Metabolism, 63(2): PP: 207-217.
27.Raschke, S., Elsen, M., Gassenhuber, H., et al. (2013). “Evidence against a beneficial effect of irisin in humans”. PLOS ONE, 8: PP: e73680.
28.
Reinehr, T.,
Elfers, C.,
Lass, N., et al. (2015).
“Irisin and Its Relation to Insulin Resistance and Puberty in Obese Children: A Longitudinal Analysis”. JCEM, 100(5): PP: 1208.
29.Roca-Rivada, A., Castelao, C., Senin, L.L., et al. (2013). “FNDC5/irisin is not only a myokine but also an adipokine”. PLOS ONE, 8: PP: e60563.
30.
Sesti, G.,
Andreozzi, F.,
Fiorentino, T.V., et al. (2014).
“High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects”.
ActaDiabetologica, 51(5): PP: 705-713.
31.
Stengel, A.,
Hofmann, T.,
Goebel-Stengel, M., et al. (2013).
“Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass index”. Peptides, 39: PP: 125-130.
32.Takeshi, Yoneshiro& Masayuki, Saito. (2015). “Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans”. Annals of Medicine, 47(2): PP: 133-141.
33.Tsuchiya, Y., Ando, D., Goto, K., et al. (2014). “High-Intensity Exercise Causes Greater Irisin Response Compared with Low-Intensity Exercise under Similar Energy Consumption”. Tohoku J Exp Med, 233(2): PP: 135-40.
34.
Zhang, H.J.,
Zhang, X.F.,
Ma, Z.M., et al. (2013).
“Irisin is inversely associated with intrahepatic triglyceride contents in obese adults”.Journal of Hepatology, 59(3): PP: 557-562.